Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine + HAAG in Elderly Newly Diagnosed AML
NCT04083911Phase 3Unknown
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Apr 2019
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of decitabine in acute myeloid leukemia (AML), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Overall Response Rate. Status: unknown.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT04083911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04083911.